Vimarsana
Biggest News Aggregation in the World

Page 7 - Mtama News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mtama. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mtama Today - Breaking & Trending Today

Tama Potaka: What's a nice Māori like you doing in the National Party? - Vimarsana News

Tama Potaka: What's a nice Māori like you doing in the National Party?

National MP on why he believes National is best for Māori.

Woman raising money to sue police department for excessive force during traffic stop - Vimarsana News

Woman raising money to sue police department for excessive force during traffic stop

The video shows a police officer pushing a woman into a car while she is on the phone.

Source: kcrg.com
Roivant Sciences Reports Financial Results for the Third Quarter Ended December 31, 2022 and Provides Business Update - Vimarsana News

Roivant Sciences Reports Financial Results for the Third Quarter Ended December 31, 2022 and Provides Business Update

$9.2M in net product revenue from VTAMA reported for the quarter ended December 31, 2022, with nearly 100,000 VTAMA prescriptions written by approximately 8,600 unique prescribers since launchVTAMA... | February 13, 2023

Dermavant Sciences: Dermavant Completes Enrollment of Two Phase 3 Clinical Trials of VTAMA (tapinarof) cream, 1% for the Treatment of Atopic Dermatitis in Adults and Children as Young as 2 years old - Vimarsana News

Dermavant Sciences: Dermavant Completes Enrollment of Two Phase 3 Clinical Trials of VTAMA (tapinarof) cream, 1% for the Treatment of Atopic Dermatitis in Adults and Children as Young as 2 years old

- ADORING 1 and 2 trials evaluating VTAMA cream in atopic dermatitis fully enrolled, with topline data expected from the first study in March 2023 and the second study in May 2023 - Dermavant recently

Dermavant Sciences, Inc.: Dermavant to Present Data from Multiple Studies of VTAMA (tapinarof) cream, 1% at the 2023 Winter Clinical Dermatology Conference - Vimarsana News

Dermavant Sciences, Inc.: Dermavant to Present Data from Multiple Studies of VTAMA (tapinarof) cream, 1% at the 2023 Winter Clinical Dermatology Conference

- Seven posters will include clinical data for VTAMA cream for the treatment of plaque psoriasis in adults and atopic dermatitis (AD), including data from the successful pediatric maximum usage study